This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

United Health Products, Inc.: Epic Wound Care Inc.'s HemoStyp™ Listed By Industry Publication Among The "Best Products Evaluated During 2012"; United Health Products Adds New Member To Board Of Directors

United Health Products, Inc. (OTCQB: UEEC.PK) and its wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, today announced that Epic Wound Care's hemostatic gauze, which is registered and branded in the USA under the trademark HemoStyp™, has been featured in the Clinicians Report ® for the second time this year. The report is a published scientific testimonial that features products which have met the criteria and approval of the dental community. The Clinicians Report ® is a 35-year-old industry publication serving as an informative tool to the dental industry with distribution to over 10,000 dental care providers. It features new products with published test results that have been tested and approved by dentists and the dental community. In the December issue HemoStyp™ was listed among the "Best Products Evaluated During 2012" with 83% of the evaluators stating that they would recommend the product. Dr. Phillip Forman, CEO of United Health Products Inc., stated that the "continued recognition from the Clinicians Report ® validates the HemoStyp™ gauze and the use of the product in the dental industry." Dr. Forman went on to say that "as a result of the prior report the company has received an initial order from one of the dental industry’s largest dental products distributors" and believes that "this new report generates the same kind of interest in the product." The Clinicians Report ® December Edition can been viewed at the following link for a nominal fee – www.cliniciansreport.org/products/dental-reports.

United Health Products, Inc. also announced the addition of Nate Knight to its Board of Directors. Mr. Knight brings to the company years of business experience and knowledge of the Company's HemoStyp™ product. Nate was a principal in Med Spring, Inc., the company that originally developed the HemoStyp™ gauze product, later acquired by United Health Products, Inc. Mr. Knight, age 64, has been a public accountant for over 30 years, has owned and operated his own accounting business, has previously held a Series 7 license, and is currently employed as an internal auditor with Prime Alliance Bank. Dr. Forman stated, "Mr. Knight, with his years of accounting experience and particular knowledge of the product as well as its potential applications, is a welcome addition to the Board of Directors."

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,960.57 -123.23 -0.72%
S&P 500 1,978.34 -9.64 -0.48%
NASDAQ 4,449.5640 -22.5440 -0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs